Here’s the Safest Way to Get Insanely Rich in the 2021 Gold Bull Market

From Resource Stock Digest | Ad

Gold is screaming higher and smart investors are already cashing in on the #1 Gold Pick of 2021. Yet, you haven’t missed the boat. See how this newly-listed US$5 gold stock offers investors historic gains without mining a single ounce of the metal.

Get the details here...

REGN Insider Trading (Regeneron Pharmaceuticals)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 11.84%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $221,745,976.65

Regeneron Pharmaceuticals Insider Trading History Chart

Regeneron Pharmaceuticals Share Price & Price History

^$496.75

▼ -1.93 (-0.39%)

As of 05/7/2021 01:00 AM ET

Days: 30 | 90 | 365

Breaking Now: Biden's Disturbing Plan to "Reset" America

From Legacy Research | Ad

The “Great Reset” started on January 20th with the inauguration of Joe Biden. Between now and the midterms, the American economy could be reshaped forever – and renowned analyst Jeff Brown has found the “lynchpin” to the entire plan.

Go here before this message is removed.

Regeneron Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/25/2021	Michael S Brown	Director	Sell	2,480	$554.32	$1,374,713.60	3,371
12/1/2020	Arthur F Ryan	Director	Sell	100	$520.48	$52,048.00	23,741
11/2/2020	Arthur F Ryan	Director	Sell	100	$548.54	$54,854.00	27,323
10/5/2020	Joseph L Goldstein	Director	Sell	9,212	$600.00	$5,527,200.00	14,855
10/5/2020	Marion Mccourt	SVP	Sell	1,000	$600.00	$600,000.00	14,963
9/22/2020	Joseph L Goldstein	Director	Sell	16,574	$549.87	$9,113,545.38
8/31/2020	George L Sing	Director	Sell	10,000	$612.06	$6,120,600.00	60,815
8/31/2020	Joseph J Larosa	EVP	Sell	4,672	$615.04	$2,873,466.88	20,438
8/25/2020	Plew Daniel P Van	EVP	Sell	27,109	$610.89	$16,560,617.01	36,854
8/24/2020	George L Sing	Director	Sell	61,000	$605.40	$36,929,400.00	111,632
8/21/2020	Joseph L Goldstein	Director	Sell	1,000	$617.18	$617,180.00	111,632
8/11/2020	P Roy Vagelos	Director	Sell	33,460	$602.94	$20,174,372.40	234,649
8/4/2020	Robert E Landry	CFO	Sell	696	$654.46	$455,504.16	23,973
8/3/2020	Arthur F Ryan	Director	Sell	100	$641.93	$64,193.00	28,640
7/21/2020	Christopher R Fenimore	VP	Sell	3,709	$642.04	$2,381,326.36	25,277
7/21/2020	Robert E Landry	CFO	Sell	391	$647.58	$253,203.78	27,473
7/14/2020	Andrew J Murphy	EVP	Sell	2,380	$633.48	$1,507,682.40	44,067
7/14/2020	Robert E Landry	CFO	Sell	579	$640.50	$370,849.50	23,973
7/8/2020	Robert E Landry	CFO	Sell	1,160	$639.66	$742,005.60	33,973
7/7/2020	George L Sing	Director	Sell	7,500	$650.00	$4,875,000.00	122,915
7/1/2020	Michael S Brown	Director	Sell	3,613	$607.62	$2,195,331.06	4,256
6/29/2020	George L Sing	Director	Sell	3,000	$608.91	$1,826,730.00	115,415
6/29/2020	Robert E Landry	CFO	Sell	400	$612.57	$245,028.00	24,334
6/19/2020	Bonnie L Bassler	Director	Sell	2,559	$630.02	$1,612,221.18	3,202
6/16/2020	Christopher R Fenimore	VP	Sell	3,556	$590.89	$2,101,204.84	20,323
6/11/2020	Huda Y Zoghbi	Director	Sell	3,412	$588.39	$2,007,586.68
6/9/2020	Robert E Landry	CFO	Sell	4,271	$606.59	$2,590,745.89
6/8/2020	Joseph L Goldstein	Director	Sell	10,838	$608.59	$6,595,898.42
6/5/2020	Bonnie L Bassler	Director	Sell	2,559	$600.00	$1,535,400.00	3,202
6/1/2020	Arthur F Ryan	Director	Sell	100	$603.23	$60,323.00	28,838
5/28/2020	George L Sing	Director	Sell	1,000	$579.00	$579,000.00	115,415
5/21/2020	P Roy Vagelos	Chairman	Sell	783	$577.49	$452,174.67	307,849
5/13/2020	George L Sing	Director	Sell	5,000	$580.00	$2,900,000.00	120,415
5/12/2020	Leonard S Schleifer	CEO	Sell	150,922	$569.22	$85,907,820.84	599,499
5/11/2020	George L Sing	Director	Sell	850	$575.00	$488,750.00	120,415
5/6/2020	Joseph L Goldstein	Director	Sell	2,000	$560.00	$1,120,000.00	7,643
5/1/2020	Arthur F Ryan	Director	Sell	100	$520.37	$52,037.00	28,931
4/20/2020	Joseph J Larosa	EVP	Sell	1,778	$570.30	$1,013,993.40	15,547
4/20/2020	Robert E Landry	CFO	Sell	3,250	$566.94	$1,842,555.00	28,373
4/17/2020	Joseph J Larosa	EVP	Sell	2,267	$557.38	$1,263,580.46	19,438
4/17/2020	Robert E Landry	CFO	Sell	991	$557.68	$552,660.88	28,373
4/15/2020	Robert E Landry	CFO	Sell	853	$518.49	$442,271.97	27,873
4/14/2020	Neil Stahl	EVP	Sell	5,497	$521.07	$2,864,321.79	24,459
4/13/2020	Robert E Landry	CFO	Sell	828	$509.79	$422,106.12	27,873
4/7/2020	Robert E Landry	CFO	Sell	696	$497.52	$346,273.92	27,373
4/2/2020	Joseph J Larosa	EVP	Sell	6,797	$489.98	$3,330,394.06	19,438
4/2/2020	Robert E Landry	CFO	Sell	105	$495.88	$52,067.40	25,092
4/1/2020	Arthur F Ryan	Director	Sell	100	$483.85	$48,385.00	29,141
4/1/2020	Christopher R Fenimore	VP	Sell	1,200	$488.41	$586,092.00	14,297
3/30/2020	Arthur F Ryan	Director	Sell	100	$466.69	$46,669.00	29,141
2/27/2020	Neil Stahl	EVP	Sell	10,349	$452.26	$4,680,438.74	36,380
2/26/2020	George L Sing	Director	Sell	2,500	$460.00	$1,150,000.00	117,915
2/25/2020	Robert E Landry	CFO	Sell	214	$449.01	$96,088.14	25,973
1/27/2020	Andrew J Murphy	EVP	Sell	8,000	$340.91	$2,727,280.00	57,751
1/2/2020	George L Sing	Director	Sell	15,000	$371.98	$5,579,700.00	130,095
12/13/2019	Christopher R Fenimore	VP	Sell	1,682	$376.14	$632,667.48	9,697
12/13/2019	P Roy Vagelos	Chairman	Sell	51,842	$376.04	$19,494,665.68	412,140
11/27/2019	Joseph L Goldstein	Director	Sell	1,000	$370.00	$370,000.00	11,323
11/26/2019	Neil Stahl	EVP	Sell	4,006	$364.07	$1,458,464.42	32,455
11/25/2019	P Roy Vagelos	Chairman	Sell	22,149	$363.83	$8,058,470.67
11/22/2019	Joseph L Goldstein	Director	Sell	1,000	$360.00	$360,000.00	11,323
11/12/2019	Michael S Brown	Director	Sell	4,500	$349.00	$1,570,500.00	4,823
11/8/2019	Joseph L Goldstein	Director	Sell	1,000	$340.44	$340,440.00	10,323
11/8/2019	Neil Stahl	EVP	Sell	7,364	$338.52	$2,492,861.28	21,150
9/10/2019	Sanofi	Major Shareholder	Sell	172,904	$281.15	$48,611,959.60
5/15/2019	Joseph L Goldstein	Director	Sell	1,000	$305.93	$305,930.00	11,323
5/14/2019	Neil Stahl	EVP	Sell	9,853	$305.74	$3,012,456.22	47,450
3/8/2019	Sanofi	Major Shareholder	Sell	131,115	$412.17	$54,041,669.55
1/10/2019	Joseph L Goldstein	Director	Sell	1,791	$410.00	$734,310.00	14,114
12/20/2018	Christopher R Fenimore	VP	Sell	1,848	$358.97	$663,376.56	9,871
12/12/2018	P Roy Vagelos	Chairman	Sell	6	$382.32	$2,293.92	387,449
9/27/2018	Michael S Brown	Director	Sell	2,000	$392.26	$784,520.00	2,000
9/24/2018	Joseph L Goldstein	Director	Sell	2,000	$388.65	$777,300.00	13,000
9/6/2018	Sanofi	Major Shareholder	Sell	104,552	$406.68	$42,519,207.36
8/22/2018	Michael S Brown	Director	Sell	1,500	$380.49	$570,735.00	1,500
8/2/2018	Joseph L Goldstein	Director	Sell	2,000	$380.00	$760,000.00	14,000
7/10/2018	P Roy Vagelos	Chairman	Sell	74,670	$367.22	$27,420,317.40	553,121
7/5/2018	Joseph L Goldstein	Director	Sell	2,000	$360.00	$720,000.00	14,000
6/21/2018	P Roy Vagelos	Chairman	Sell	74,710	$327.87	$24,495,167.70	553,121
6/8/2018	Sanofi	Major Shareholder	Sell	121,601	$309.31	$37,612,405.31
5/24/2018	Neil Stahl	EVP	Sell	11,407	$295.09	$3,366,091.63	58,709
5/9/2018	George L Sing	Director	Sell	7,000	$285.29	$1,997,030.00	127,772

SEC Filings (Institutional Ownership Changes) for Regeneron Pharmaceuticals (NASDAQ:REGN)

85.00% of Regeneron Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Regeneron Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/7/2021	Advisors Asset Management Inc.	16,993	$8.04M	0.1%	-21.8%	0.016%
5/7/2021	BlackRock Inc.	9,649,548	$4.57B	0.1%	-1.3%	9.007%
5/7/2021	American International Group Inc.	45,235	$21.40M	0.1%	-2.5%	0.042%
5/7/2021	Cambridge Investment Research Advisors Inc.	11,481	$5.43M	0.0%	-16.4%	0.011%
5/7/2021	Pzena Investment Management LLC	1,255	$0.59M	0.0%	N/A	0.001%
5/7/2021	Claudia M.P. Batlle CRP R LLC	7,443	$3.52M	2.6%	+12.4%	0.007%
5/7/2021	Cannell Peter B & Co. Inc.	13,006	$6.15M	0.2%	-42.7%	0.012%
5/7/2021	Alberta Investment Management Corp	53,120	$25.13M	0.2%	+45.9%	0.050%
5/7/2021	Cibc World Markets Corp	14,065	$6.66M	0.0%	-51.0%	0.013%
5/7/2021	D.A. Davidson & CO.	461	$0.22M	0.0%	N/A	0.000%
5/7/2021	Sowell Financial Services LLC	376	$0.19M	0.0%	-25.1%	0.000%
5/7/2021	Reynders McVeigh Capital Management LLC	1,389	$0.66M	0.0%	-11.1%	0.001%
5/7/2021	Graypoint LLC	687	$0.33M	0.0%	+3.3%	0.001%
5/7/2021	Harvey Capital Management Inc.	11,057	$5.23M	1.9%	N/A	0.010%
5/7/2021	Amica Mutual Insurance Co.	4,341	$2.05M	0.2%	-5.5%	0.004%
5/7/2021	Swiss National Bank	606,822	$287.11M	0.2%	+1.8%	0.566%
5/7/2021	IndexIQ Advisors LLC	7,896	$3.74M	0.1%	+452.9%	0.007%
5/7/2021	The PNC Financial Services Group Inc.	11,156	$5.28M	0.0%	-14.0%	0.010%
5/7/2021	Advisors Preferred LLC	3,785	$1.80M	0.3%	N/A	0.004%
5/7/2021	Keybank National Association OH	514	$0.24M	0.0%	-25.9%	0.000%
5/7/2021	Altfest L J & Co. Inc.	945	$0.45M	0.1%	N/A	0.001%
5/7/2021	Sumitomo Mitsui DS Asset Management Company Ltd	8,103	$3.83M	0.1%	+3.4%	0.008%
5/7/2021	Brighton Jones LLC	482	$0.23M	0.0%	-21.5%	0.000%
5/7/2021	Fifth Third Bancorp	19,902	$9.42M	0.0%	-14.8%	0.019%
5/7/2021	Livforsakringsbolaget Skandia Omsesidigt	6,906	$3.27M	0.2%	+13.1%	0.006%
5/7/2021	Asahi Life Asset Management CO. LTD.	905	$0.43M	0.1%	-14.2%	0.001%
5/6/2021	Arizona State Retirement System	29,549	$13.98M	0.1%	-2.0%	0.028%
5/6/2021	Marietta Wealth Management LLC	4,504	$2.13M	0.5%	N/A	0.004%
5/6/2021	First National Bank of Omaha	9,860	$4.67M	0.2%	+16.1%	0.009%
5/6/2021	Blueshift Asset Management LLC	2,282	$1.08M	0.1%	N/A	0.002%
5/6/2021	Rhumbline Advisers	165,250	$78.19M	0.1%	-5.0%	0.154%
5/6/2021	Girard Partners LTD.	5,719	$2.71M	0.4%	N/A	0.005%
5/6/2021	Twin Capital Management Inc.	6,029	$2.85M	0.3%	-12.1%	0.006%
5/6/2021	Sigma Planning Corp	1,469	$0.70M	0.0%	+22.9%	0.001%
5/6/2021	Harvest Investment Services LLC	6,133	$2.90M	1.3%	+0.6%	0.006%
5/6/2021	Harvest Volatility Management LLC	2,282	$1.08M	0.1%	+62.1%	0.002%
5/6/2021	Bank of Nova Scotia	20,633	$9.76M	0.0%	+10.2%	0.019%
5/6/2021	Abundance Wealth Counselors	100	$47K	0.0%	N/A	0.000%
5/6/2021	Alliancebernstein L.P.	2,077,251	$982.83M	0.4%	+17.8%	1.939%
5/6/2021	WP Advisors LLC	3,014	$1.43M	0.6%	N/A	0.003%
5/6/2021	Koshinski Asset Management Inc.	463	$0.22M	0.0%	-14.7%	0.000%
5/6/2021	Suncoast Equity Management	44,440	$21.03M	3.1%	+44.3%	0.041%
5/6/2021	Greenwich Wealth Management LLC	16,179	$7.66M	0.6%	+0.3%	0.015%
5/6/2021	Scotia Capital Inc.	9,996	$4.73M	0.0%	+0.4%	0.009%
5/6/2021	Penbrook Management LLC	810	$0.38M	0.3%	+710.0%	0.001%
5/6/2021	Mitsubishi UFJ Kokusai Asset Management Co. Ltd.	37,691	$17.83M	0.1%	+14.3%	0.035%
5/6/2021	Analyst IMS Investment Management Services Ltd.	2,805	$1.33M	0.2%	+35.8%	0.003%
5/6/2021	Standard Life Aberdeen plc	74,052	$35.05M	0.1%	+106.3%	0.069%
5/6/2021	Fagan Associates Inc.	7,469	$3.53M	0.8%	+10.4%	0.007%
5/6/2021	Copperwynd Financial LLC	920	$0.44M	0.2%	+47.9%	0.001%
5/6/2021	Wesbanco Bank Inc.	2,770	$1.31M	0.1%	N/A	0.003%
5/6/2021	M&T Bank Corp	4,096	$1.94M	0.0%	-26.7%	0.004%
5/6/2021	Kovitz Investment Group Partners LLC	1,258	$0.60M	0.0%	N/A	0.001%
5/5/2021	Augustine Asset Management Inc.	5,253	$2.49M	1.3%	+0.7%	0.005%
5/5/2021	Shikiar Asset Management Inc.	1,617	$0.77M	0.3%	-69.3%	0.002%
5/5/2021	Seizert Capital Partners LLC	84,577	$40.02M	2.1%	+74.1%	0.079%
5/5/2021	Wade G W & Inc.	2,649	$1.25M	0.1%	+85.0%	0.002%
5/5/2021	Interchange Capital Partners LLC	380	$0.26M	0.1%	+347.1%	0.000%
5/5/2021	Slow Capital Inc.	2,176	$1.03M	0.3%	-17.2%	0.002%
5/5/2021	Penbrook Management LLC	810	$0.38M	0.3%	+710.0%	0.001%
5/5/2021	Asio Capital LLC	1,770	$0.84M	0.3%	N/A	0.002%
5/5/2021	Unigestion Holding SA	7,271	$3.44M	0.1%	-56.3%	0.007%
5/5/2021	Los Angeles Capital Management LLC	25,644	$12.13M	0.1%	+625.8%	0.024%
5/5/2021	Signet Financial Management LLC	3,867	$1.83M	0.3%	-3.2%	0.004%
5/5/2021	Kendall Capital Management	2,398	$1.14M	0.7%	+5.4%	0.002%
5/5/2021	Magnus Financial Group LLC	743	$0.35M	0.1%	-21.4%	0.001%
5/5/2021	Cowa LLC	838	$0.40M	0.2%	N/A	0.001%
5/5/2021	IFM Investors Pty Ltd	11,543	$5.46M	0.1%	+15.2%	0.011%
5/5/2021	Natixis Advisors L.P.	138,338	$65.45M	0.3%	-3.5%	0.129%
5/4/2021	Envestnet Asset Management Inc.	64,762	$30.64M	0.0%	+5.4%	0.060%
5/4/2021	Hedeker Wealth LLC	4,862	$2.30M	0.8%	+0.5%	0.005%
5/4/2021	Great Diamond Partners LLC	971	$0.46M	0.1%	-4.5%	0.001%
5/4/2021	Commonwealth Equity Services LLC	14,206	$6.72M	0.0%	+20.2%	0.013%
5/4/2021	Sterling Investment Advisors Ltd.	3,903	$1.85M	0.6%	+13,839.3%	0.004%
5/4/2021	Traynor Capital Management Inc.	12,643	$5.98M	1.0%	+4.0%	0.012%
5/4/2021	Migdal Insurance & Financial Holdings Ltd.	1,376	$0.65M	0.0%	+166.7%	0.001%
5/4/2021	Victory Capital Management Inc.	83,161	$39.35M	0.0%	-4.7%	0.078%
5/4/2021	Ieq Capital LLC	578	$0.27M	0.0%	N/A	0.001%
5/4/2021	Pillar Pacific Capital Management LLC	9,667	$4.57M	0.4%	+4.9%	0.009%
5/4/2021	Asset Management Corp IL ADV	855	$0.41M	0.2%	N/A	0.001%
5/3/2021	Nikko Asset Management Americas Inc.	79,618	$37.67M	0.2%	+47.7%	0.074%
5/3/2021	General American Investors Co. Inc.	11,501	$5.44M	0.5%	N/A	0.011%
5/3/2021	Meyer Handelman Co.	2,245	$1.06M	0.0%	N/A	0.002%
5/3/2021	The Manufacturers Life Insurance Company	103,725	$49.08M	0.0%	+7.5%	0.097%
5/3/2021	Symmetry Partners LLC	593	$0.28M	0.0%	-47.6%	0.001%
5/3/2021	Treasurer of the State of North Carolina	46,083	$21.80M	0.1%	+1.8%	0.043%
5/3/2021	Daiwa Securities Group Inc.	7,642	$3.62M	0.0%	+12.1%	0.007%
5/3/2021	Zurcher Kantonalbank Zurich Cantonalbank	52,454	$24.82M	0.1%	+13.3%	0.049%
5/3/2021	Texas Permanent School Fund	17,581	$8.32M	0.1%	-4.9%	0.016%
5/3/2021	Hendershot Investments Inc.	15,584	$7.37M	1.7%	+55.0%	0.015%
5/3/2021	Oxler Private Wealth LLC	2,280	$1.08M	0.5%	+33.3%	0.002%
5/3/2021	Raymond James Trust N.A.	859	$0.41M	0.0%	-46.5%	0.001%
4/30/2021	Ground Swell Capital LLC	703	$0.33M	1.1%	N/A	0.001%
4/30/2021	Signaturefd LLC	732	$0.35M	0.0%	-19.5%	0.001%
4/30/2021	Markel Corp	45,500	$21.53M	0.3%	N/A	0.042%
4/30/2021	MUFG Americas Holdings Corp	1,686	$0.80M	0.0%	-44.9%	0.002%
4/30/2021	Virginia Retirement Systems ET AL	127,300	$60.23M	0.6%	+5.8%	0.119%
4/30/2021	Wealthstreet Investment Advisors LLC	36,986	$17.50M	1.7%	-2.5%	0.035%
4/30/2021	Exane Derivatives	375	$0.18M	0.1%	+7.8%	0.000%
4/30/2021	CWM Advisors LLC	7,269	$3.44M	0.5%	+46.5%	0.007%

Data available starting January 2016

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various medical conditions worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macular edema following retinal vein occlusion, including macular edema following central retinal vein occlusion and macular edema following branch retinal vein occlusion. It also provides Dupixent injection to treat atopic dermatitis in adults, and asthma in adults and adolescents; Praluent injection for heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease in adults; and Kevzara solution for subcutaneous injection for treating rheumatoid arthritis in adults. In addition, the company offers Libtayo injection to treat metastatic or locally advanced cutaneous squamous cell carcinoma; ARCALYST injection for cryopyrin-associated periodic syndromes, including familial cold auto-inflammatory syndrome and muckle-wells syndrome; and ZALTRAP injection for intravenous infusion to treat metastatic colorectal cancer. Further, it offers Inmazeb injection for infection caused by Zaire ebolavirus; and develops product candidates for treating patients with eye, allergic and inflammatory, cancer, cardiovascular and metabolic, pain, infectious, and other diseases. The company has collaboration and license agreements with Sanofi; Bayer; Teva Pharmaceutical Industries Ltd.; Mitsubishi Tanabe Pharma Corporation; Alnylam Pharmaceuticals, Inc.; Roche Pharmaceuticals; and Kiniksa Pharmaceuticals, Ltd., as well as has an agreement with the U.S. Department of Health and Human Services. It has collaborations with Zai Lab Limited; Intellia Therapeutics, Inc.; and Biomedical Advanced Research Development Authority. Regeneron Pharmaceuticals, Inc. was founded in 1988 and is headquartered in Tarrytown, New York.

Today's Range

Now: $496.75

$492.81

$503.00

50 Day Range

MA: $482.80

$460.32

$506.48

52 Week Range

Now: $496.75

$441.00

$664.64

Volume

703,341 shs

Average Volume

979,380 shs

Market Capitalization

$53.22 billion

P/E Ratio

18.16

Dividend Yield

N/A

Beta

0.3

Who are the company insiders with the largest holdings of Regeneron Pharmaceuticals?

Regeneron Pharmaceuticals' top insider investors include:

Leonard S Schleifer (CEO)
P Roy Vagelos (Chairman)
P Roy Vagelos (Director)
George L Sing (Director)
Joseph L Goldstein (Director)
Andrew J Murphy (EVP)
Neil Stahl (EVP)
Plew Daniel P Van (EVP)
Robert E Landry (CFO)
Arthur F Ryan (Director)
Christopher R Fenimore (VP)
Joseph J Larosa (EVP)
Marion Mccourt (SVP)
Michael S Brown (Director)
Bonnie L Bassler (Director)
Huda Y Zoghbi (Director)
Sanofi (Major Shareholder)

Who are the major institutional investors of Regeneron Pharmaceuticals?

Regeneron Pharmaceuticals' top institutional investors include:

BlackRock Inc. — 9.01%
Alliancebernstein L.P. — 1.94%
Swiss National Bank — 0.57%
Sumitomo Mitsui Trust Holdings Inc. — 0.46%
LSV Asset Management — 0.24%
Assenagon Asset Management S.A. — 0.18%

Which institutional investors are selling Regeneron Pharmaceuticals stock?

In the previous quarter, REGN stock was sold by these institutional investors:

BlackRock Inc.
Robeco Institutional Asset Management B.V.
FDx Advisors Inc.
Cibc World Markets Corp
LSV Asset Management
Cannell Peter B & Co. Inc.
Unigestion Holding SA
Rhumbline Advisers

During the previous year, company insiders that have sold Regeneron Pharmaceuticals company stock include:

Leonard S Schleifer (CEO)
P Roy Vagelos (Chairman)
P Roy Vagelos (Director)
George L Sing (Director)
Joseph L Goldstein (Director)
Andrew J Murphy (EVP)
Neil Stahl (EVP)
Plew Daniel P Van (EVP)
Robert E Landry (CFO)
Arthur F Ryan (Director)
Christopher R Fenimore (VP)
Joseph J Larosa (EVP)
Marion Mccourt (SVP)
Michael S Brown (Director)
Bonnie L Bassler (Director)

Which institutional investors are buying Regeneron Pharmaceuticals stock?

During the last quarter, REGN stock was purchased by institutional investors including:

Alliancebernstein L.P.
Retirement Systems of Alabama
Sumitomo Mitsui Trust Holdings Inc.
Markel Corp
Bronte Capital Management Pty Ltd.
Standard Life Aberdeen plc
Seizert Capital Partners LLC
Assenagon Asset Management S.A.

Biden Set To Trigger Major Devaluation of the U.S. Dollar

From Legacy Research | Ad

The U.S. dollar is in free fall and many analysts are predicting the crash will continue under President Biden.

Banks across the country are already preparing. The agency that regulates all banks in the U.S. issued this new rule that will change everything.

If you have money in the bank…